Internal Medicine, Endocrinology, Diabetes, & Metabolism · East Stroudsburg, PA
NPI
1265846539
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
179 Independence Rd
East Stroudsburg, PA, 18301
Phone (570) 426-2330
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
8,538 services
Medicare patients, 2024
275
Average age 72
Drug cost, 2024
$1.6M
3,194 prescriptions
Company payments, 2025
$193
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana Tenpenny was code J0897 (injection, denosumab, 1 mg), 1,980 times for 22 patients. In total Diana Tenpenny billed 8,538 services in 18 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,980 | 22 | $20.34 | $40K |
| 99214 Office E&M - Established | Office | 254 | 189 | $84.18 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 130 | $12.22 | $1,832 |
| 95251 Test - Miscellaneous | Office | 66 | 44 | $23.96 | $1,581 |
| 96372 Injection Administration | Office | 60 | 29 | $9.85 | $591 |
| 99204 Office E&M - New | Office | 41 | 41 | $109.28 | $4,481 |
| 99215 Office E&M - Established | Office | 40 | 30 | $110.18 | $4,407 |
| 99451 E&M - Miscellaneous | Office | 22 | 22 | $19.27 | $424 |
| 83036 Blood Count | Office | 16 | 15 | $9.52 | $152 |
| 82044 Clinical Chemistry | Office | 15 | 15 | $6.11 | $91.65 |
By year: 2022 $55K for 2,068 services; 2023 $91K for 5,625 services; 2024 $126K for 8,538 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 16 | 15 | $9.52 | $152 |
| 82044 Clinical Chemistry | 15 | 15 | $6.11 | $91.65 |
Medicare prescription drug claims, 2024
In 2024, the drug Diana Tenpenny prescribed most often to Medicare patients was Levothyroxine Sodium, with 206 prescriptions and refills. In total Diana Tenpenny wrote 3,194 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 206 | 570 | 74 | $2,749 |
| Metformin Hcl Generic | 165 | 412 | 53 | $1,376 |
| Ozempic Semaglutide | 120 | 220 | 31 | $199K |
| Metformin Hcl Er Metformin Hcl | 119 | 298 | 38 | $2,466 |
| Jardiance Empagliflozin | 118 | 275 | 39 | $155K |
| Mounjaro Tirzepatide | 116 | 163 | 27 | $169K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 111 | 250 | 52 | $16K |
| Farxiga Dapagliflozin Propanediol | 105 | 233 | 26 | $125K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 104 | 269 | 47 | $11K |
| Tresiba Flextouch U-100 Insulin Degludec | 89 | 236 | 36 | $91K |
| Glipizide Generic | 86 | 213 | 28 | $1,168 |
| Trulicity Dulaglutide | 80 | 124 | 25 | $119K |
| Lisinopril Generic | 79 | 213 | 23 | $317 |
| Alendronate Sodium Generic | 67 | 165 | 22 | $479 |
| Methimazole Generic | 66 | 174 | 18 | $569 |
Brand drugs: 1,494 claims; generic drugs: 1,314 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana Tenpenny $193 ($193 in general payments such as food, travel and fees) from 4 companies. The largest payer was Amgen Inc. with $109.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.